Last reviewed · How we verify
MART
At a glance
| Generic name | MART |
|---|---|
| Sponsor | Brigham and Women's Hospital |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma (PHASE2)
- Improving the Quality of Care for Asthma Patients at Risk of Exacerbations (NA)
- RCT-Consumer Perceptions of Cannabidiol (CBD) Health Claims (NA)
- Effects of Beclometasone Dipropionate/Formoterol Fumarate Via NEXT(Haler) in a Real-world Study on Asthma Control
- Comparative Effects of Muscle Energy Technique and Modified Active Release Technique in Scapulocostal Syndrome. (NA)
- CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma (PHASE4)
- Vascular Supply Identification, Lesion Extension and Search for Tumor Similarity at a Distance by VTM in Breast Cancer (NA)
- Individualizing Treatment for Asthma in Primary Care (Full Study) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MART CI brief — competitive landscape report
- MART updates RSS · CI watch RSS
- Brigham and Women's Hospital portfolio CI